The levels of total cholesterol, triglycerides, and low-density lipoprotein (LDL) cholesterol among the breast cancer patient group were significantly higher than those among both benign breast disease patients and healthy women (P < 0.05), except for high-density lipoprotein (HDL) cholesterol....
The lifetime cost effectiveness of HMG-CoA reductase inhibitors (fluvastatin, lovastatin, pravastatin, simvastatin) and fibrates (bezafibrate, fenofibrate, gemfibrozil) for the treatment of primary hyperlipidemia varied according to patient population, the effectiveness of each drug in modifying lipid levels...
View PDFView articleView in ScopusGoogle Scholar [25] L. Wang, W. Liu, X. He, Y. Chen, J. Lu, K. Liu, et al. Association of overweight and obesity with patient mortality after acute myocardial infarction: a meta-analysis of prospective studies Int. J. Obes., 40 (2) (2016), pp...
skip to main content skip to article journals & books help search my account sign in access through your organization purchase pdf patient access other access options search sciencedirect article preview section snippets references (17) cited by (1) atherosclerosis volume 365 , january 2023 , pages...
Risk factors and co-morbidities were determined either by patient report (smoking) or by chart review (e.g. hyperlipidemia, diabetes, stroke). Information on AMI characteristics and treatment (e.g. AMI type, type of reperfusion therapy) as well as in-hospital complications (e.g. cardiac ...
The individual approach consists of a two-step nutritional strategy, depending on the patient. Indeed, the first approach to low cardiovascular risk in children should be the Cardiovascular Health Integrated Lifestyle Diet-1 (CHILD-1), which shares the same recommendations as the population strategy...
Intervention patients have more education years, higher income, lower Body Mass Index (BMI), and are less likely to be on simultaneous antihypertensive and lipid-lowering medications (p < 0.05). These variables were covariates in the multivariate analysis (see Table 2). Table 2. Patient ...